| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Gwenn Hansen is Chief Scientific Officer at NRIX. From November 2020 to November 2026, the filings on record show 0 open-market purchases and 40 sales. Gwenn Hansen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.2M at current prices.
Historically, Gwenn Hansen's trades have earned a strong insider score of 70/100 across 35 rated trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +22.1%.
The NRIX filings lean toward selling, a net 80,920 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,412 | $11.78 | $16,632.80 | -5.8% | -16.6% | -32.7% | |
| Oct 31, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,165 | $12.88 | $15,005.78 | -5.2% | -6.8% | -56.1% | |
| Aug 1, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,186 | $15.67 | $18,584.62 | -5.8% | -17.4% | -38.4% | |
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,098 | $11.75 | $12,901.50 | -6.0% | +28.8% | -21.4% | |
| Jan 3, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,828 | $28.96 | $52,938.88 | -11.4% | -51.1% | -63.4% | |
| Dec 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $29.13 | $11,652.00 | -2.7% | -45.3% | -57.1% | |
| Nov 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $33.24 | $13,296.00 | -2.7% | -46.0% | -61.8% | |
| Oct 27, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.7% | -42.6% | -64.0% | |
| Oct 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $29.92 | $11,968.00 | -2.7% | -4.0% | -58.3% | |
| Sep 7, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,600 | $35.00 | $56,000.00 | -10.1% | -21.2% | -54.2% |